Zobrazeno 1 - 10
of 158
pro vyhledávání: '"L Bacigalupo"'
Autor:
Pablo Carabias, María V. Espelt, María L. Bacigalupo, Paola Rojas, Luciana Sarrias, Ayelén Rubin, Nicolás A. Saffioti, María T. Elola, Juan P. Rossi, Carlota Wolfenstein-Todel, Gabriel A. Rabinovich, María F. Troncoso
Publikováno v:
Cell Death and Disease, Vol 13, Iss 1, Pp 1-14 (2022)
Abstract Galectin-1 (GAL1), a β-galactoside-binding protein abundantly expressed in the tumor microenvironment, has emerged as a key mechanism of chemoresistance developed by different tumors. Although increased expression of GAL1 is a hallmark of h
Externí odkaz:
https://doaj.org/article/70ad9085a3b84ba1a29e96851ae21f89
Autor:
María L Bacigalupo, Verónica G Piazza, Nadia S Cicconi, Pablo Carabias, Andrzej Bartke, Yimin Fang, Ana I Sotelo, Gabriel A Rabinovich, María F Troncoso, Johanna G Miquet
Publikováno v:
Endocrine Connections, Vol 8, Iss 8, Pp 1108-1117 (2019)
Transgenic mice overexpressing growth hormone (GH) spontaneously develop liver tumors, including hepatocellular carcinoma (HCC), within a year. The preneoplastic liver pathology in these mice recapitulates that observed in humans at high risk of deve
Externí odkaz:
https://doaj.org/article/b33d034c83684217b8fa29d8cb688f3c
Publikováno v:
Revista de Gastroenterología de México, Vol 85, Iss 1, Pp 88-89 (2020)
Externí odkaz:
https://doaj.org/article/2d4d417e928541f3b173c433659afaeb
Publikováno v:
Revista de Gastroenterología de México (English Edition), Vol 85, Iss 1, Pp 88-89 (2020)
Externí odkaz:
https://doaj.org/article/14f3546a5e074fa1a6c910c2c293b5e2
Publikováno v:
Revista de Gastroenterología de México, Vol 85, Iss 1, Pp 88-89 (2020)
Publikováno v:
Revista de gastroenterologia de Mexico (English). 85(1)
Publikováno v:
World Journal of Hepatology
Hepatocellular carcinoma (HCC) has an elevated mortality rate, largely because of high recurrence and metastasis. Additionally, the main obstacle during treatment of HCC is that patients usually develop resistance to chemotherapy. Cancer drug resista
Autor:
María T. Elola, María V. Espelt, Gabriel A. Rabinovich, María F. Troncoso, Pablo Carabias, María L. Bacigalupo, Malena Manzi, Carlota Wolfenstein-Todel
Publikováno v:
Journal of Cellular Physiology. 231:1522-1533
Galectin-1 (Gal1), a β-galactoside-binding protein elevated in hepatocellular carcinoma (HCC), promotes epithelial-mesenchymal transition (EMT) and its expression correlates with HCC growth, invasiveness, and metastasis. During the early stages of H
Autor:
Malena Manzi, Lucas Daniel Gentilini, María L. Bacigalupo, María V. Espelt, Carlota Wolfenstein-Todel, Gabriel A. Rabinovich, María F. Troncoso, Daniel Compagno, Diego Jose Laderach
Publikováno v:
Journal of Cellular Physiology. 230:1298-1309
Galectin-1 (Gal1), a β-galactoside-binding protein abundantly expressed in tumor microenvironments, is associated with the development of metastasis in hepatocellular carcinomas (HCC). However, the precise roles of Gal1 in HCC cell invasiveness and
Autor:
Lucas Daniel Gentilini, María L. Bacigalupo, Fátima Ferragut, Diego Jose Laderach, Gabriel A. Rabinovich, Víctor M. Cárdenas Delgado, María T. Elola, Daniel Compagno, Lorena G. Nugnes, María F. Troncoso, Carlota Wolfenstein-Todel
Publikováno v:
CONICET Digital (CONICET)
Consejo Nacional de Investigaciones Científicas y Técnicas
instacron:CONICET
Consejo Nacional de Investigaciones Científicas y Técnicas
instacron:CONICET
Galectin-8 (gal-8) is a "tandem-repeat"-type galectin, containing two carbohydrate recognition domains connected by a linker peptide. gal-8 is expressed both in the cytoplasm and nucleus in vascular endothelial cells (ECs) from normal and tumor-assoc